Huberman Lab: Peptides, GLP-1s & Safety Risks Explained with Dr. Abud Bakri

Peptides may be reshaping health, fitness, and longevity—but the biggest question is which ones are truly evidence-based and which are still guesswork. This condensed recap turns Andrew Huberman’s full conversation with Dr. Abud Bakri into a minutes-long overview, saving you time while covering the science, uses, and safety of peptides like GLP-1 agonists, BPC-157, thymosin alpha-1, epitalon, and other longevity compounds. Learn why some peptides have clear mechanisms and clinical data, why others remain poorly understood, and how the gray market raises contamination and quality-control risks. Huberman and Bakri also discuss immune aging, thymus support, sleep science, tissue repair, and the limits of animal studies versus rigorous human trials. If you’re searching for practical insight on peptides, wellness, recovery, and current medical trends, this summary distills the key ideas fast. Listen now to get the key ideas in minutes.